[HTML][HTML] Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline …

L Von Seidlein, S Auburn, F Espino, D Shanks… - Malaria journal, 2013 - Springer
The diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency
is a crucial aspect in the current phases of malaria control and elimination, which will require …

[HTML][HTML] Methods for the field evaluation of quantitative G6PD diagnostics: a review

B Ley, G Bancone, L Von Seidlein, K Thriemer… - Malaria journal, 2017 - Springer
Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at risk of
severe haemolysis following the administration of 8-aminoquinoline compounds …

[HTML][HTML] Validation of G6PD point-of-care tests among healthy volunteers in Yangon, Myanmar

NN Oo, G Bancone, LZ Maw, N Chowwiwat, P Bansil… - PloS one, 2016 - journals.plos.org
Primaquine and other 8-amnoquinoline based anti-malarials can cause haemolysis in
subjects with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Correct diagnosis of …

[HTML][HTML] First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea

YK Goo, SY Ji, HI Shin, JH Moon, SH Cho, WJ Lee… - PloS one, 2014 - journals.plos.org
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common
human enzyme defect and affects more than 400 million people worldwide. This deficiency …

[HTML][HTML] Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: divergent policies and practices in malaria endemic countries

J Recht, EA Ashley, NJ White - PLoS neglected tropical diseases, 2018 - journals.plos.org
Primaquine is the only available antimalarial drug that kills dormant liver stages of
Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse …

Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities

GJ Domingo, N Advani, AW Satyagraha… - International …, 2019 - academic.oup.com
Abstract Glucose-6-phosphate dehyrdgoenase (G6PD) deficiency is a common X-linked
genetic trait, with an associated enzyme phenotype, whereby males are either G6PD …

[HTML][HTML] Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical …

N Carter, A Pamba, S Duparc, JN Waitumbi - Malaria journal, 2011 - Springer
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is common in
populations living in malaria endemic areas. G6PD genotype and phenotype were …

[HTML][HTML] Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion

G Bancone, D Menard, N Khim, S Kim, L Canier… - Malaria journal, 2019 - Springer
Background Plasmodium vivax malaria elimination can only be achieved by the deployment
of 8-aminoquinolines (primaquine and tafenoquine) in combination with ACT to kill both …

[HTML][HTML] Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda

M De Niz, AC Eziefula, L Othieno, E Mbabazi… - Malaria journal, 2013 - Springer
Background The distribution of the enzymopathy glucose-6-phosphate dehydrogenase
(G6PD) deficiency is linked to areas of high malaria endemicity due to its association with …

[HTML][HTML] Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening

S Kim, C Nguon, B Guillard, S Duong, S Chy, S Sum… - PloS one, 2011 - journals.plos.org
Development of reliable, easy-to-use, rapid diagnostic tests (RDTs) to detect glucose-6-
phosphate dehydrogenase (G6PD) deficiency at point of care is essential to deploying …